Loomis, Sayles & Company
KYTH

Loomis, Sayles & Company’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Loomis, Sayles & Company’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-81,973
Closed -$3.26M – 807
2014
Q1 		$3.26M Buy
+81,973
New +$3.67M 0.01% 552

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Loomis, Sayles & Company's KYTH Position: Q2 2014 in Review

Loomis, Sayles & Company sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2014, closing a stake of 81,973 shares — an estimated $3.26M sold.

Loomis, Sayles & Company first reported a position in KYTH in Q1 2014 and held it in 1 quarter. The position peaked at $3.26M in Q1 2014. 104 funds tracked by Wall St. Rank hold KYTH as of Q2 2014.

  • Loomis, Sayles & Company reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2014 after selling out during the quarter.
  • Loomis, Sayles & Company sold 81,973 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2014, an estimated $3.26M.
  • Loomis, Sayles & Company first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 1 quarter.
  • Loomis, Sayles & Company's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $3.26M in Q1 2014.
  • 104 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2014.

Based on Loomis, Sayles & Company's 13F filing for Q2 2014, filed 14 Aug 2014.